⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

December 1, 2025

Darier's Disease Successfully Treated with Tofacitinib: A Case Report.

Elham Behrangi Abbas Dehghani Roya Zeinali Shila Amiri

View Full Paper

Ask AI

Bookmark

Share

Key Points

Tofacitinib shows effectiveness in treating darier's disease, particularly in refractory cases.
Case report highlights successful treatment outcomes for this chronic skin condition.
Treatment involved the use of JAK inhibitors, a promising class of medications for skin disorders.
Findings support further exploration of JAK inhibitors for managing chronic dermatological diseases.

Implication

Case report demonstrates effective treatment with tofacitinib in a patient with refractory darier's disease, suggesting potential for JAK inhibitors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Behrangi et al. (2025) studied this question.

synapsesocial.com/papers/6930e8cdea1aef094cca38bd https://doi.org/10.1159/000548764

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature2024 · 9 citations
2Janus kinase inhibitors as a breakthrough treatment for refractory dissecting cellulitis of the scalp2025 · 4 citations
3JAK inhibitors in refractory dermatomyositis: A case series2024 · 7 citations
4Multivessel Coronary Artery Disease in a Patient Treated With Tofacitinib: A Case Reportcase_report · 2025 · 1 citations
5Tofacitinib successful treatment of idiopathic twenty-nail dystrophy: a case report2025